Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Healthcare Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > two additional CR and 1 remission?
View:
Post by SundayMovies on Mar 22, 2023 10:21am

two additional CR and 1 remission?

Pancreatic trial (goblet) is still ongoing but it is not unrealistic to expect two additional CR and one case of cancer free / cured patient:

Patient 002 (from PR to CR)
Patient 012 (from PR to CR)

Patient 013 (from CR to total remission)

If so, this is not a fluke and get accelerated approval.
Comment by westcoast1000 on Mar 22, 2023 12:53pm
Sunday, Could you provide the basis for your "not realistic" expectation? Why do you think these outcomes are even possible ?
Comment by westcoast1000 on Mar 22, 2023 2:05pm
should be: "not unrealistic"...
Comment by SundayMovies on Mar 22, 2023 2:33pm
Check out slides 17 and 18 of powerpoint presentation
Oncolytics Biotech Inc